#collette roche

[unitedbydevils]

United unveils new £7m women's facility at Carrington

Manchester United football club has unveiled a new "high performance" facility (their words) at the Carrington training complex in Greater Manchester.

United's owners have long been criticised for the lack of renovation performed on both Old Trafford and Carrington under their stewardship, so it's a welcome move to see additional space created for the women's side - at a time when the women's team is steadily growing in stature and success.

Speaking to the BBC, United's chief operating officer Collette Roche said: "The women's team is something we take really seriously at Manchester United," said Roche. "That is why we have backed this facility and we are all behind making sure our women's team is a success."

Back in May 2021 then-manager Casey Stoney quit as United manager following rumour of unrest behind the scenes regarding United's management as an organisation. A spate of injuries that coincided with her team being forced to train at Leigh Sports Village, near Wigan, rather than at the Carrington complex and additional problems such as inappropriate changing rooms and amateur facilities were also flagged up. Even when Stoney's protests forced a move to Carrington, the women's side then played second fiddle to the men due to the scheduling of facility usage.

Fast forward a few months to September 2021 and United's website announced planning proposals had been submitted to Trafford Council to approve a spate of changes, including two bespoke new pavilions (women's and academy), new toilets, floodlights, and a new all-seater stand. It's unclear how much of these proposals have been added now beyond the pavilions however.

Polly Bancroft, Head of Women’s Football, also spoke to BBC Sport, adding: "England isn't the only country that is investing in women's football, but now we have created a fantastic environment for players and staff to continue building. Obviously standards are getting higher, so this gives us a competitive advantage, domestically and internationally.

"We don't want this European campaign to be a flash in the pan. We want to be playing in Europe regularly. This is a new experience for us and we hope there are many more to come."

For more information you can see the official club video teaser of the new facilities below.

[thesportsnews]

Man Utd to remove executive seats from Stretford End

Collette Roche, chief operating officer at Manchester United, said: “Structural work will take place over the coming year to return the Stretford End to general admission seating and create a new concourse. During this period, we will be consulting fans to understand how best to repurpose the space currently used by the International Suite. “We very much value our executive club members who…

[cryptonews256]

Man Utd to remove executive seats from Stretford End

Collette Roche, chief operating officer at Manchester United, said: “Structural work will take place over the coming year to return the Stretford End to general admission seating and create a new concourse. During this period, we will be consulting fans to understand how best to repurpose the space currently used by the International Suite. “We very much value our executive club members who…

[futurejunglist]

Future Jungle Sessions #94 // 8K.NZ Radio // April 2022

https://linktr.ee/gwarden_nz 

LIVE on 8K.NZ ~ SAT 19:00 (NZST) // MON 13:00 // WED 05:00 // FRI 22:00

Alix Perez - Desanka [1985 Music]

Digital Native - Forever and Ever [Goldfat Records]

Athena - Dreamverse [Shogun Audio]

Think Tonk - Our Love In F# Minor [Spearhead Records]

Dazee, Collette Warren - You Wish [Intrigue Music]

Paul SG - King's Town [Jazzsticks Recordings]

Mitekiss, Milo Merah - River So Deep [Hospital Records]

K Motionz - Shutdown Season [K Motionz Music]

P Money, Whiney - Buss The Red [Hospital Records]

Break, Total Science - Gun Finger [Triii Audio]

Dr. Apollo & dela Moon - Don't Sleep [Together with Ukraine]

The Upbeats - Foleys [Together with Ukraine]

BTK - Ruff Amen [Dutty Audio]

Total Science - Jungle Jungle (Remastered) [Metalheadz]

Digital Native - Present and Tense [Goldfat Records]

NC-17 & Dr. Apollo - Beauty [Together with Ukraine]

Black Barrel - Bad Boy Tune [Dispatch Recordings]

Monty & Halogenix - Fools [Together with Ukraine]

Basstripper - Lightspeed [Radar Records]

aBLe, Cesco - Move Your Car [Monk Audio]

Dutta, Emperor - Make Me [Souped Up Records]

Trakker - Sorry [Sofa Sound]

The Sauce - Shaken Not Stirred [The Sauce Recordings]

Entita - Wrong Place [Delta9 Recordings]

Alcemist - Look At U [DnB Allstars Records]

Mandidextrous - Trust the Lasers [Program]

Noisia, Former - Pleasure Model (Synergy Remix) [Vision Recordings]

Volatile Cycle, Dropset - Baltic [Ekou Recordings]

Censored the Audio - Moco [Incurzion Audio]

Teej, Scepticz - Turbulence [Midas Touch Recordings]

Dunk, MC Gusto - The Legacy [The Mob Recordings]

Fluidity - Never Ever [Integral Records]

Rohaan - Cavity [Unchained Recordings]

Spektiv - Chiaro [Transparent Audio]

Ezor - Breathe It [Ekou Recordings]

Felix Raymon, Invadhertz, Jamal Dilmen - Too Late [Flexout Audio]

Undecentum, Roche - So Real [Allstars RAW]

A K A - Exit Point [Ekou Recordings]

Annix & Simula - On You [Together with Ukraine]

Cybin - Consequences [Intrigue Music]

Adred - Levitation [ThirtyOne Recordings]

Ed:it - The Other Tune [Together with Ukraine]

Invert Era, Was A Be - 6 Degrees [Onyx Recordings]

LOPHT - Loose Ends [Chronic]

Theoretical - King [Data Music]

Conrad Subs - Like No One Before [Formation Records]

Charlie B - Jungle Soul [Deep In The Jungle Records]

Break, Total Science - Acquiesce [Triii Audio]

Unglued - The Original Funky Drummer [Together with Ukraine]

[tkmedia]

Man Utd announce planned improvements to Carrington Training Centre

Manchester United have announced various planned improvements to the club’s training complex at Carrington, including additional changing facilities, gyms, offices and an all-seater stand.The plans are in addition to renovations already carried out over the summer, with pitches rebuilt, women’s team facilities refurbished and restaurant areas upgraded. Ole Gunnar Solskjaer’s office was also given new life with a lick of paint.The club has explained that planning applications will be submitted to build ‘two new bespoke pavilions to host additional changing facilities, offices, gyms and catering areas’, with plans for overflow car parking also ‘in the pipeline’.The planning applications seeking approval for ‘new floodlights, a new all-seater stand, improved access footpaths, pitchside toilets, an electricity sub-station and new fencing along the east side of the training centre’ have already been submitted to Trafford Council.The new all-seater stand with a capacity of close to 500 people is proposed as a replacement for two existing smaller stands adjacent to one of the training pitches.It will have a ‘built-in broadcast and performance analysis platform’ and ‘provide comfortable seating for players, coaches, staff, scouts and other visitors’.“Longer term, we are looking at fuller redevelopment plans for Carrington to ensure it will be a state-of-the-art, fully integrated facility for our men’s, women’s and academy groups,” chief operating officer Collette Roche told ManUtd.com.“In the meantime, our team have been working exceptionally hard over the summer and into this season on these improvements.“Part of the challenge for us is to create an inclusive place for everyone who works and trains at Carrington, while making sure that it is a COVID-secure environment.“We also want to make the site more accessible for those who may need to use a wheelchair or have disabilities. The new stand and access pathways are important parts of that.”One of the biggest criticisms towards the Glazer family at the peak of the European Super League scandal had been a lack of investment over the last decade on the club’s infrastructure and facilities.Frustration over the standard of women’s team training facilities made available was also a major part of the reason Casey Stoney unexpectedly resigned her position as United manager in May.For more from Jamie Spencer, follow him on Twitter and Facebook! Read the full article

[youressentialsblog]

Man Utd finalising plans for new Fan Advisory Board and expanded Fans Forum

Man Utd finalising plans for new Fan Advisory Board and expanded Fans Forum

The Terms of Reference and composition of both bodies have been agreed in consultation with the existing Fans’ Forum, and with MUST in its capacity as the accredited independent fan group representing Manchester United supporters. Collette Roche, Manchester United Chief Operating Officer, said: “We are pleased with the progress made so far towards building a framework for more effective…

[subterraneanhq]

Hey, kids! Below the cut is a list of people who haven’t updated their sideblogs in the last two weeks. As was mentioned in this note on the gossip blog, sideblog updates count as part of your activity. The biweekly task isn’t required, but updates are. Anyone below the cut is at risk of receiving a role hogging warning on our next big check, so update those sideblogs!

P.S. Also please put your character’s name in the sideblog description to make the lives of our gossip bloggers much easier. Thank you!

Jaime Preciado

Miles Heizer

Noah Sebastian

Noelle Collett

Norah Roche

Trevor Collins

[todaynewsstories]

U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million

ZURICH (Reuters) – Just weeks after Novartis floated the idea that $4-5 million was fair value for its new gene therapy against a deadly neuromuscular disease, a major benefits manager is pushing back.

Eight-year-old Victoria Gusset sits in her wheelchair as she plays in her room at home in Heimbach, Switzerland October 31, 2018. Picture taken October 31, 2018. REUTERS/Arnd Wiegmann

The Swiss drugmaker’s assessment of AVXS-101’s value for treating spinal muscular atrophy (SMA) has put the company front-and-center in the debate over what “super drugs”, for rare diseases afflicting relatively few patients, are really worth.

Among the first to react was pharmacy benefits manager Express Scripts, which helps U.S. employers manage workers’ prescription costs.

Its chief medical officer, Steve Miller, told Reuters he “loves the science” behind Novartis’s therapy, a potential cure for newborns who are diagnosed early.

But $4 million or more per patient?

“You just can’t keep pushing these price points up,” Miller said. “I just don’t think we can allow it. It is not sustainable over time.”

Novartis, which bought U.S.-based AveXis for $8.7 billion in April to add the SMA therapy to its portfolio, is still mulling its asking price as it awaits U.S. Food and Drug Administration approval, likely in early 2019.

But the company has begun its campaign to convince insurance groups and governments to cover AVXS-101, contending the one-and-done infusion will save society money over the long haul, even with a cost near the highest ever for a one-time therapy.

There’s now only one approved drug for SMA, Biogen’s two-year-old Spinraza, and it is listed at $750,000 for the first year and $350,000 thereafter. Spinraza is not a cure and must be taken indefinitely.

“When we look at 10-year costs, you see somewhere between $2.5 million to $5 million being spent by societies to care for these types of patients,” Dave Lennon, AveXis’s president, said.

“Four million dollars is a significant amount of money, but we believe this is a cost-effective point.”

Though newborns may stand to benefit the most from AVXS-101, depending on the durability of its effect, the therapy is also being tested in older SMA patients with more advanced disease in hopes it will improve their symptoms, too.

A CHILD’S LIFE

A diagnosis of SMA, which affects one in 10,000 live births, is devastating. Forty percent of victims have the severest form and historically die within months.

Children with less severe SMA can live to adulthood, although with profound physical disabilities. Though cognitively normal, many cannot feed themselves and require 24-hour care, wheelchairs and machines to help them breathe and cough.

Janice Kress, a Pennsylvania woman, lost her grandson to the disease at 5 months.

Today she volunteers for SMA charity events and knows families who have fought their U.S. insurers for access to Biogen’s Spinraza, as payers seek to rein in costs using eligibility criteria like age or when symptoms began.

“A child’s life — how can you say no?” Kress said.

PRICE WATCHDOG

As Novartis prepares to launch AVXS-101, it also hopes for tacit endorsement of its pricing strategy from the non-profit Institute for Clinical and Economic Review (ICER), which is currently reviewing the cost-effectiveness of SMA therapies.

The Boston-based non-profit, established in 2006, carries out cost-benefit analyses on drugs that it calls independent of “Big Pharma”, insurers and government.

Unlike European price regulators, ICER cannot dictate costs.

But it has steadily gained influence in the U.S. pricing debate, as companies like Express Scripts and CVS Caremark and governments rely on its analyses.

ICER has conducted 11 assessments in 2018, some covering multiple drugs.

In seven of the reviews, it concluded drugs’ prices aligned with their benefits, like when it said Roche’s $482,000 hemophilia medicine Hemlibra could save the U.S. system up to $1.9 million for the hardest-to-treat patients.

Four times, however, ICER concluded drugmakers were asking too much, giving payers ammunition to bargain them down.

For instance, the New York Department of Health told Reuters that ICER’s finding that a $270,000-per-year cystic fibrosis drug from Vertex Pharmaceuticals represented “low long-term value” helped underpin the state’s demand for a steep discount.

JUST ONE FINGER

Novartis and Biogen, as well as Switzerland’s Roche, which also has an SMA drug in development, are all lobbying ICER to broaden what it considers a meaningful benefit, potentially helping their therapies fare well in the group’s review.

The ability to move one finger might not seem like much, but Biogen told ICER such a measure should be considered, since it might allow somebody with SMA to steer an electric wheelchair and maintain a level of independence.

“We recently spoke with a young man who is…now losing ability and power in his fingers,” said Sangeeta Jethwa, Roche’s head of patient partnerships, told Reuters.

“He wants to be able to go out with his friends and open his own bottle of drink. That for him is fantastically meaningful.”

For its SMA review, ICER aims to quantify factors like quality of life, direct medical costs and how patient and caregiver productivity losses may burden society.

A head-to-head comparison of Spinraza’s and AVXS-101’s financial impacts over time is also planned before ICER issues its final report in March.

ICER spokesman David Whitrap said ICER’s review takes eight months so it can “rigorously evaluate all of the available evidence.”

The stakes are high for Biogen, after Britain’s healthcare cost agency, the National Institute for Health and Care Excellence, has concluded Spinraza was too expensive to be cost-effective.

Though Spinraza, whose nine-month 2018 sales hit $1.25 billion, is available in the United States and elsewhere in Europe, Biogen wants to avoid a negative ICER assessment that gives payers more leverage to demand rebates.

“We are confident in the evidence supporting the value it provides,” a Biogen spokeswoman said.

SIGNS OF PROGRESS

Treatments for rare diseases like SMA are increasingly popular among drugmakers, because they command high prices while insurers are hard pressed to reject claims, especially for sick children.

Sales of rare disease therapies will rise 11 percent annually, nearly twice the overall market rate, through 2024, when they’ll hit $262 billion, consultancy Evaluate Pharma has forecast.

Novartis Chief Executive Vas Narasimhan, with ambitions of treating hundreds of SMA patients annually, highlights 90 kids in AVXS-101 trials over four years, including some who would otherwise have been incapacitated and fed through tubes.

“With AVXS-101… patients are alive and thriving,” Narasimhan said.

There were no SMA therapies, however, when Victoria Gusset, an eight-year-old Swiss girl with a shy smile and love for horses, was diagnosed as a toddler after failing to stand independently.

Today, Victoria is in a trial testing how Spinraza may improve muscle control or halt its decline in older children.

Every four months, Victoria and her mother, Nicole Gusset, load her electric wheelchair into their van and drive two hours from their home near Bern to a German hospital for a spinal infusion.

Victoria looks forward to each trip, though she sometimes suffers from nausea and headaches following treatment.

“I get to go shopping with mum,” she said.

After her daughter’s diagnosis, Nicole Gusset founded an SMA patient organization and has been lobbying the Swiss government to expand access to Spinraza. Children under 20 have coverage, but most insurers refuse to pay for adults.

Slideshow (6 Images)

Gusset said Novartis’s $4 million announcement sent shockwaves through Switzerland’s SMA community, heightening fears that escalating costs will keep new treatments out of reach for some who might benefit.

“The best therapies are useless if patients cannot get them,” she said.

(the story vorrects paragraph 22 to show ICER conducted 11 assessments in 2018, not reviewed 11 treatments)

Reporting by John Miller in Zurich, Deena Beasley in Los Angeles and Caroline Humer in New York; Editing by Mike Collett-White

Our Standards:The Thomson Reuters Trust Principles.

Source link

The post U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million appeared first on Today News Stories.

from WordPress https://ift.tt/2DHUJsw via IFTTT

[newestbalance]

UK Vogue names

LONDON (Reuters) – Meghan Markle was named among the 25 most influential women in Britain on Thursday, according to a list published by UK Vogue magazine which hailed her as forging a new identity for the monarchy.

Meghan, Duchess of Sussex attends a garden party at Buckingham Palace, in London, Britain May 22, 2018. Dominic Lipinski/Pool via Reuters

Prince Harry’s wife Markle, now called the Duchess of Sussex, was named alongside Scottish politician Ruth Davidson, fashion designer Stella McCartney and Harry Potter author J.K. Rowling in the fashion publication’s inaugural “The Vogue 25”.

It highlighted influential women working in sectors such as arts and entertainment, science, politics, media and law.

Markle, whose star-studded wedding celebrations at Windsor Castle this month were watched by millions of people around the globe, was described as “one of the most recognizable women in the world”.

“Her influence stretches far beyond the ceaseless coverage of her style – as a bi-racial campaigning feminist from America, she is helping to forge a new 21st-century identity for the monarchy,” British Vogue wrote on its website.

It hailed Scottish Conservative leader Davidson’s “relatable personality and progressive ideas” and said McCartney ran “one of the most forward-thinking and powerful independent houses in fashion”.

Other names to make the list of influential women, whose ages range from 22 to 73, include human rights lawyer Amal Clooney, singer Dua Lipa, models Adwoa Aboah and Edie Campbell and Manchester United Chief Operating Officer Collette Roche.

Reporting by Marie-Louise Gumuchian; Editing by Alison Williams

The post UK Vogue names appeared first on World The News.

from World The News https://ift.tt/2sly0fr via Everyday News

[dani-qrt]

UK Vogue names

LONDON (Reuters) – Meghan Markle was named among the 25 most influential women in Britain on Thursday, according to a list published by UK Vogue magazine which hailed her as forging a new identity for the monarchy.

Meghan, Duchess of Sussex attends a garden party at Buckingham Palace, in London, Britain May 22, 2018. Dominic Lipinski/Pool via Reuters

Prince Harry’s wife Markle, now called the Duchess of Sussex, was named alongside Scottish politician Ruth Davidson, fashion designer Stella McCartney and Harry Potter author J.K. Rowling in the fashion publication’s inaugural “The Vogue 25”.

It highlighted influential women working in sectors such as arts and entertainment, science, politics, media and law.

Markle, whose star-studded wedding celebrations at Windsor Castle this month were watched by millions of people around the globe, was described as “one of the most recognizable women in the world”.

“Her influence stretches far beyond the ceaseless coverage of her style – as a bi-racial campaigning feminist from America, she is helping to forge a new 21st-century identity for the monarchy,” British Vogue wrote on its website.

It hailed Scottish Conservative leader Davidson’s “relatable personality and progressive ideas” and said McCartney ran “one of the most forward-thinking and powerful independent houses in fashion”.

Other names to make the list of influential women, whose ages range from 22 to 73, include human rights lawyer Amal Clooney, singer Dua Lipa, models Adwoa Aboah and Edie Campbell and Manchester United Chief Operating Officer Collette Roche.

Reporting by Marie-Louise Gumuchian; Editing by Alison Williams

The post UK Vogue names appeared first on World The News.

from World The News https://ift.tt/2sly0fr via Online News

[party-hard-or-die]

UK Vogue names

LONDON (Reuters) – Meghan Markle was named among the 25 most influential women in Britain on Thursday, according to a list published by UK Vogue magazine which hailed her as forging a new identity for the monarchy.

Meghan, Duchess of Sussex attends a garden party at Buckingham Palace, in London, Britain May 22, 2018. Dominic Lipinski/Pool via Reuters

Prince Harry’s wife Markle, now called the Duchess of Sussex, was named alongside Scottish politician Ruth Davidson, fashion designer Stella McCartney and Harry Potter author J.K. Rowling in the fashion publication’s inaugural “The Vogue 25”.

It highlighted influential women working in sectors such as arts and entertainment, science, politics, media and law.

Markle, whose star-studded wedding celebrations at Windsor Castle this month were watched by millions of people around the globe, was described as “one of the most recognizable women in the world”.

“Her influence stretches far beyond the ceaseless coverage of her style – as a bi-racial campaigning feminist from America, she is helping to forge a new 21st-century identity for the monarchy,” British Vogue wrote on its website.

It hailed Scottish Conservative leader Davidson’s “relatable personality and progressive ideas” and said McCartney ran “one of the most forward-thinking and powerful independent houses in fashion”.

Other names to make the list of influential women, whose ages range from 22 to 73, include human rights lawyer Amal Clooney, singer Dua Lipa, models Adwoa Aboah and Edie Campbell and Manchester United Chief Operating Officer Collette Roche.

Reporting by Marie-Louise Gumuchian; Editing by Alison Williams

The post UK Vogue names appeared first on World The News.

from World The News https://ift.tt/2sly0fr via Breaking News

[anneentertainment]

Man Utd: Collette Roche to become club's first female chief operating officer - https://youtu.be/Dg0jU9H-rx8

[activeukworld]

Man Utd set to appoint club's first female chief operating officer

Manchester United are set to appoint Collette Roche as the club's first female chief operating officer, BBC Sport understands. via RSSMix.com Mix ID 8133830 https://ift.tt/2H8s8iJ

[tkmedia]

Man Utd to face Rooney's Derby, QPR, Brentford & Everton as pre-season plans announced

Man Utd to face Rooney's Derby, QPR, Brentford & Everton as pre-season plans announced | Goal.comManchester United

Last Updated5 minutes ago09:45Jun 22, 2021Link copiedCommentsGetty ImagesThe Red Devils will have two matches staged at Old Trafford before the start of the 2021-22 campaign, with a tour abroad not being possibleManchester United have announced four games to be played in England as part of their pre-season plans. Ole Gunnar Solskjaer’s side will face Derby, QPR, Brentford and Everton as they prepare for the new season.  The latter two games will be played at Old Trafford and, should there be no further setbacks to the government's easing of restrictions, fans will be allowed into the stadium, in accordance with Covid-19 guidelines.  Editors' Picks When are the games?  Solskjaer’s side kick off their pre-season away to Wayne Rooney’s Derby on July 18 before a week-long UK-based training camp. They will then take on QPR at the Kiyan Prince Foundation Stadium on July 24, before two matches at Old Trafford against Brentford and Everton respectively. The fixture against the Championship play-off winners will be played on July 28, while the meeting with the Toffees is scheduled for August 7. The new Premier League season kicks off on August 13, with United’s opener against Leeds being played at lunchtime on August 14. Why aren't United going abroad? Goal can confirm the club has been exploring a number of options with regards to playing games abroad and a potential training camp on warmer shores. However, government travel legislation has made planning very difficult, with requirements to quarantine after travelling in from the vast majority of countries.  Ordinarily United would travel to a far-flung destination, their last tour in 2019 took in Australia, China and a game in Norway, but the current status of the pandemic means this has not been possible.  Due to the short break between campaigns last year, Solskjaer’s side barely managed to have a pre-season due to their Europa League commitments. They squeezed in one game against Aston Villa and their poor start to the campaign was blamed on their lack of pre-season preparations.Article continues below What's been said?  Manchester United's chief operating officer, Collette Roche said following confirmation of the pre-season schedule: "This year’s pre-season schedule has been planned with the current travel restrictions in mind, whilst providing Ole and the players with the best possible preparations for the new season. "Playing two pre-season matches at Old Trafford will also give us another opportunity to welcome fans back safely into the stadium ahead of the new Premier League season." Further reading Link copiedComments Read the full article

[365footballorg-blog]

Man Utd set to appoint club's first female chief operating officer Manchester United are set to appoint Collette Roche as the club's first female chief operating officer.